These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31467120)

  • 1. ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions.
    Bourdin A; Bjermer L; Brightling C; Brusselle GG; Chanez P; Chung KF; Custovic A; Diamant Z; Diver S; Djukanovic R; Hamerlijnck D; Horváth I; Johnston SL; Kanniess F; Papadopoulos N; Papi A; Russell RJ; Ryan D; Samitas K; Tonia T; Zervas E; Gaga M
    Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31467120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EAACI position statement on asthma exacerbations and severe asthma.
    Custovic A; Johnston SL; Pavord I; Gaga M; Fabbri L; Bel EH; Le Souëf P; Lötvall J; Demoly P; Akdis CA; Ryan D; Mäkelä MJ; Martinez F; Holloway JW; Saglani S; O'Byrne P; Papi A; Sergejeva S; Magnan A; Del Giacco S; Kalayci O; Hamelmann E; Papadopoulos NG
    Allergy; 2013 Dec; 68(12):1520-31. PubMed ID: 24410781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paediatrics in Barcelona.
    Midulla F; Lombardi E; Rottier B; Lindblad A; Grigg J; Bohlin K; Rusconi F; Pohunek P; Eber E
    Eur Respir J; 2014 Aug; 44(2):457-74. PubMed ID: 24833764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [GINA 2014: Yin and Yang].
    Kardos P
    Pneumologie; 2014 Dec; 68(12):784-7. PubMed ID: 25489866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Severe Asthma].
    Hagmeyer L; Randerath WJ
    Dtsch Med Wochenschr; 2015 Oct; 140(20):1524-8. PubMed ID: 26445257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA(2)LEN.
    Carlsen KH; Anderson SD; Bjermer L; Bonini S; Brusasco V; Canonica W; Cummiskey J; Delgado L; Del Giacco SR; Drobnic F; Haahtela T; Larsson K; Palange P; Popov T; van Cauwenberge P; ; ;
    Allergy; 2008 May; 63(5):492-505. PubMed ID: 18394123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.
    Chung KF; Wenzel SE; Brozek JL; Bush A; Castro M; Sterk PJ; Adcock IM; Bateman ED; Bel EH; Bleecker ER; Boulet LP; Brightling C; Chanez P; Dahlen SE; Djukanovic R; Frey U; Gaga M; Gibson P; Hamid Q; Jajour NN; Mauad T; Sorkness RL; Teague WG
    Eur Respir J; 2014 Feb; 43(2):343-73. PubMed ID: 24337046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma.
    Ivanova JI; Bergman R; Birnbaum HG; Colice GL; Silverman RA; McLaurin K
    J Allergy Clin Immunol; 2012 May; 129(5):1229-35. PubMed ID: 22326484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of asthma during the Coronavirus disease 2019 outbreak.
    Taillé C; Chenivesse C; Devouassoux G; Bourdin A; Garcia G; ;
    Respir Med Res; 2020 Nov; 78():100762. PubMed ID: 32805635
    [No Abstract]   [Full Text] [Related]  

  • 10. Exercise-induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LEN.
    Carlsen KH; Anderson SD; Bjermer L; Bonini S; Brusasco V; Canonica W; Cummiskey J; Delgado L; Del Giacco SR; Drobnic F; Haahtela T; Larsson K; Palange P; Popov T; van Cauwenberge P; ;
    Allergy; 2008 Apr; 63(4):387-403. PubMed ID: 18315727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tele-monitoring of ventilator-dependent patients: a European Respiratory Society Statement.
    Ambrosino N; Vitacca M; Dreher M; Isetta V; Montserrat JM; Tonia T; Turchetti G; Winck JC; Burgos F; Kampelmacher M; Vagheggini G;
    Eur Respir J; 2016 Sep; 48(3):648-63. PubMed ID: 27390283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Report from an Annual Congress of the European Respiratory Society, Stockholm, 15-19 September 2007 (part II)].
    Kuca P; Kuś J; Pływaczewski R; Radzikowska E; Górecka D; Zieliński J
    Pneumonol Alergol Pol; 2008; 76(4):286-95. PubMed ID: 18785135
    [No Abstract]   [Full Text] [Related]  

  • 13. An international observational prospective study to determine the cost of asthma exacerbations (COAX).
    Lane S; Molina J; Plusa T
    Respir Med; 2006 Mar; 100(3):434-50. PubMed ID: 16099149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
    Galiè N; Humbert M; Vachiery JL; Gibbs S; Lang I; Torbicki A; Simonneau G; Peacock A; Vonk Noordegraaf A; Beghetti M; Ghofrani A; Gomez Sanchez MA; Hansmann G; Klepetko W; Lancellotti P; Matucci M; McDonagh T; Pierard LA; Trindade PT; Zompatori M; Hoeper M
    Eur Respir J; 2015 Oct; 46(4):903-75. PubMed ID: 26318161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence and disease burden of severe eosinophilic asthma in Japan.
    Nagasaki T; Sato K; Kume N; Oguma T; Sunadome H; Ito I; Izuhara Y; Okamoto K; Kobayashi S; Ohno T; Mizukami A; Kobayashi A; Kaise T; Kuroda T; Mishima M; Matsumoto H
    J Asthma; 2019 Nov; 56(11):1147-1158. PubMed ID: 30822174
    [No Abstract]   [Full Text] [Related]  

  • 16. Comment on: International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.
    Wechsler ME; Cox GP
    Eur Respir J; 2014 Jul; 44(1):267. PubMed ID: 24982058
    [No Abstract]   [Full Text] [Related]  

  • 17. Comment on: International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.
    Hahn DL
    Eur Respir J; 2014 Jul; 44(1):266. PubMed ID: 24982057
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of an integrated disease management program in reducing exacerbations in patients with severe asthma and COPD.
    Jain VV; Allison R; Beck SJ; Jain R; Mills PK; McCurley JW; Van Gundy KP; Peterson MW
    Respir Med; 2014 Dec; 108(12):1794-800. PubMed ID: 25294691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updated guidelines (2015) for management and monitoring of adult and adolescent asthmatic patients (from 12 years and older) of the Société de Pneumologie de Langue Française (SPLF) (Full length text).
    Raherison C; Bourdin A; Bonniaud P; Deslée G; Garcia G; Leroyer C; Taillé C; De Blic J; Dubus JC; Tillié-Leblond I; Chanez P
    Rev Mal Respir; 2016 Apr; 33(4):279-325. PubMed ID: 27147308
    [No Abstract]   [Full Text] [Related]  

  • 20. ERS/EAACI statement on adherence to international adult asthma guidelines.
    Mathioudakis AG; Tsilochristou O; Adcock IM; Bikov A; Bjermer L; Clini E; Flood B; Herth F; Horvath I; Kalayci O; Papadopoulos NG; Ryan D; Sanchez Garcia S; Correia-de-Sousa J; Tonia T; Pinnock H; Agache I; Janson C
    Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34526316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.